Announcements Trials

Browse Landscape

Phase

Phase 2 42 Phase 1 15 Phase 1/2 12 Phase 3 6 Phase EARLY_PHASE1 2 Phase 2/3 2 Phase 4 1

Status

Completed 2 Active not recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Propofol 9 Sevoflurane 7 Rituximab 7 Specimen Handling 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Trastuzumab 5 Enoxaparin 5 Bevacizumab 5 Nivolumab 4 Carboplatin 4 Capecitabine 4 Bupivacaine 4 trametinib 3 pirtobrutinib 3 pembrolizumab 3 dabrafenib 3 atezolizumab 3 apixaban 3 Lenalidomide 3 Indocyanine Green 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 ribociclib 2 polyethylene glycol 3350 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × olaparib × Clear all

NCT05078671 2024-06-12

PROACTIVE

Radboud University Medical Center

Phase 4 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡